title: Topiramate for migraine prophylaxis among Chinese population.
abstract: We evaluated the efficacy and safety of topiramate for migraine prophylaxis among Chinese patients in a multicenter prospective observational study. We found that topiramate at low doses was effective in preventing migraine headache in Chinese patients and was generally well tolerated. There was no difference in baseline headache frequency or intensity between responders and nonresponders.
authors: Department of Medicine and Geriatrics, Princess Margaret Hospital, Hong Kong, China.
authors: Ho Lun
authors: HL
authors: Li
authors: Patrick
authors: P
authors: Kwan
authors: Howan
authors: H
authors: Leung
authors: Evelyn
authors: E
authors: Yu
authors: Tak Hong
authors: TH
authors: Tsoi
authors: Andrew Che Fai
authors: AC
authors: Hui
authors: Bun
authors: B
authors: Sheng
authors: Kwok Kwong
authors: KK
authors: Lau
mesh_terms: D000328:Adult; D044466:Asian People; D005260:Female; D005632:Fructose / Q000031:analogs & derivatives* / Q000627:therapeutic use; D006801:Humans; D008297:Male; D008875:Middle Aged; D008881:Migraine Disorders / Q000453:epidemiology* / Q000517:prevention & control*; D018696:Neuroprotective Agents / Q000627:therapeutic use*; D019370:Observation; D011446:Prospective Studies; D013997:Time Factors; D000077236:Topiramate
chemical_list: D018696:Neuroprotective Agents; D000077236:Topiramate; D005632:Fructose